2 news items
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
ALDX
25 Apr 24
will be accessible from the "Investors & Media" section of the Aldeyra website
Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
ALDX
18 Apr 24
and slide presentation will be accessible from the "Investors & Media" section of the Aldeyra website
- Prev
- 1
- Next